InvestorsHub Logo

PG

Followers 105
Posts 871
Boards Moderated 0
Alias Born 03/27/2013

PG

Re: BurntToast post# 84704

Saturday, 07/13/2013 11:30:42 AM

Saturday, July 13, 2013 11:30:42 AM

Post# of 158400
Lawdy, them skeeter's must have been carrying M1 Garand's; they tore my butt up! And I have too much surface area on these bones to be messing with those buggers for too long. Even my blue chartreuse Skitter Pop said "let's get out of Dodge".

First off: ENTB & BMSN are California entities now. They both are active and up-to-date with all filings in the state of California. The Nevada BMSN filings EXPIRED before ENTB's due to the filing date(s) of both. Both are bonafide California busineses.

Second: As much as I love to argue with ole one-eye, he is absolutely spot on with respect to the share structure of both companies. Though I have my own theory which differs from some as to why Koos is presently diluting ENTB, he is diluting nonetheless. This does not bother me per se' and I intend to continue to accumulate at these prices.

Although BMSN & ENTB are discovering similar treatments for the same diseases, the monetary potential of BMSN with human treatment versus that of ENTB's animal treatment is like comparing that 2 ft Pike I caught last week with the ittle bitty yallow perch found in his belly (I don't eat Pike. Yuck! But the ole' country folk down the way love 'em!). Mind you, that is not to say that ENTB will not be poised to earn major $$$ once their treatments are 100% ready for market. But, you must bear in mind that in the not-so-distant future, the human pharma business will be about 1.1 trillion V the apx. 13 billion spent on animal pharma. There is no comparison.

What else? Oh, as I have stated numerous times in a myriad of ways, we are talking about treating/curing debilitating and fatal diseases by stem cell proliferation. In the grand scheme of treatment, it is still very new. The art of making someone's life as difficult as possible is not so new with the FDA. Or any branch of any government for that matter. All indicators as they have been presented by the great minds that have been feverishly working on the sciences that BMSN now possess, say that there is no reason for trials not to be initiated in the near future. We just have to be patient.

BMSN!


Sometimes, you just have to walk away, let the dust settle and look at it all from a different perspective.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.